Department of General Surgery, Nanfang Hospital of Southern Medical University, Guangzhou 510515, Guangdong Province, China.
World J Gastroenterol. 2013;19(14):2197-207. doi: 10.3748/wjg.v19.i14.2197.
To investigate the regulative effect of miRNA-338-3p (miR-338-3p) on cell growth in colorectal carcinoma (CRC).
The lentiviral vector pLV-THM-miR-338-3p and pLV-THM-miR-338-3p-inhibitor were constructed. The recombinant viral vector encoding the pre-miR-338-3p or miR-338-3p-inhibitor and the two packaging plasmids psPAX2 and pMD2.G were cotransfected into human embryonic kidney 293T cells to package lentivirus. The supernatant containing the lentivirus particles was harvested to determine the viral titer, and this supernatant was then used to transduce CRC-derived cell line, SW-620. Flow cytometry was utilized for sorting the green fluorescent protein (GFP)⁺ cells to establish the SW-620 cell line stably expressing pre-miR-338-3p or miR-338-3p-inhibitor. Moreover, the expression of miR-338-3p was determined by real-time reverse transcriptase polymerase chain reaction, and Western blotting was used to detect the expression of the smoothened (SMO, the possible target of miR-338-3p) protein in SW-620 cells. Furthermore, the status of CRC cell proliferation and apoptosis were detected by 3-(4,5-dimethyl-2 thiazoyl)-2,5-diphenyl-2H-tetrazolium bromide assay and flow cytometry, respectively.
Restriction enzyme digestion and DNA sequencing demonstrated that the lentiviral vector pLV-THM-miR-338-3p and pLV-THM-miR-338-3p-inhibitor were constructed successfully. GFP was expressed after the SW-620 cells were transduced by the lentivirus. Expression of miR-338-3p in SW-620 cells transduced with the lentivirus pLV-THM-miR-338-3p was significantly increased (relative expression 3.91 ± 0.51 vs 2.36 ± 0.44, P < 0.01). Furthermore, overexpression of miR-338-3p inhibited the expression of SMO protein in SW-620 cells, which showed obviously suppressed proliferation ability [cellular proliferation inhibition rate (CPIR) 61.9% ± 5.2% vs 41.6% ± 4.8%, P < 0.01]. Expression of miR-338-3p in SW-620 cells transduced with the lentivirus pLV-THM-miR-338-3p-inhibitor was significantly decreased (relative expression 0.92 ± 0.29 vs 2.36 ± 0.44, P < 0.01). Moreover, the downregulated expression of miR-338-3p caused upregulated expression of the SMO protein in SW-620 cells, which showed significantly enhanced proliferation ability (CPIR 19.2% ± 3.8% vs 41.6% ± 4.8%, P < 0.01). However, anti-SMO-siRNA largely, but not completely, reversed the effects induced by blockage of miR-338-3p, suggesting that the regulative effect of miR-338-3p on CRC cell growth was indeed mediated by SMO.
miR-338-3p could suppress CRC growth by inhibiting SMO protein expression.
研究微小 RNA-338-3p(miR-338-3p)对结直肠癌细胞生长的调节作用。
构建慢病毒载体 pLV-THM-miR-338-3p 和 pLV-THM-miR-338-3p 抑制剂。将编码前 miR-338-3p 或 miR-338-3p 抑制剂的重组病毒载体与 psPAX2 和 pMD2.G 两种包装质粒共转染入人胚肾 293T 细胞中进行慢病毒包装。收获含有慢病毒颗粒的上清液以确定病毒滴度,然后用该上清液转导结直肠癌细胞系 SW-620。利用流式细胞术分选绿色荧光蛋白(GFP)⁺细胞,建立稳定表达前 miR-338-3p 或 miR-338-3p 抑制剂的 SW-620 细胞系。此外,通过实时逆转录聚合酶链反应检测 miR-338-3p 的表达,并用 Western blot 检测 SW-620 细胞中 smoothened(SMO,miR-338-3p 的可能靶标)蛋白的表达。进一步通过 3-(4,5-二甲基-2 噻唑基)-2,5-二苯基-2H-四唑溴盐(MTT)比色法和流式细胞术分别检测 CRC 细胞增殖和凋亡的状态。
酶切和 DNA 测序验证慢病毒载体 pLV-THM-miR-338-3p 和 pLV-THM-miR-338-3p 抑制剂构建成功。SW-620 细胞转染慢病毒后表达 GFP。慢病毒 pLV-THM-miR-338-3p 转导的 SW-620 细胞中 miR-338-3p 的表达明显增加(相对表达 3.91±0.51 对 2.36±0.44,P<0.01)。此外,miR-338-3p 的过表达抑制了 SW-620 细胞中 SMO 蛋白的表达,导致其增殖能力明显受到抑制[细胞增殖抑制率(CPIR)61.9%±5.2%对 41.6%±4.8%,P<0.01]。慢病毒 pLV-THM-miR-338-3p 转导的 SW-620 细胞中 miR-338-3p 的表达明显降低(相对表达 0.92±0.29 对 2.36±0.44,P<0.01)。此外,miR-338-3p 表达下调导致 SMO 蛋白在 SW-620 细胞中表达上调,使其增殖能力明显增强(CPIR 19.2%±3.8%对 41.6%±4.8%,P<0.01)。然而,抗 SMO-siRNA 大部分但不完全逆转了 miR-338-3p 阻断引起的效应,提示 miR-338-3p 对 CRC 细胞生长的调节作用确实是通过 SMO 介导的。
miR-338-3p 可通过抑制 SMO 蛋白表达抑制结直肠癌细胞生长。